Buprenorphine dosing for the treatment of opioid use disorder through pregnancy and postpartum
CE Martin, C Shadowen, B Thakkar, T Oakes… - … treatment options in …, 2020 - Springer
Purpose of review Opioid-related deaths are a leading cause of mortality during pregnancy
through 12 months postpartum. Buprenorphine use during pregnancy is increasing, yet …
through 12 months postpartum. Buprenorphine use during pregnancy is increasing, yet …
[PDF][PDF] An overview on medication-assisted treatment (MAT) for opioid dependence
AS Xavier, SK Behera, S Selvarajan - Journal of Opioid …, 2020 - researchgate.net
In this article, a broad overview of medication-assisted treatment (MAT) for opioid
dependence has been provided. Significant benefits of commonly used drugs …
dependence has been provided. Significant benefits of commonly used drugs …
Factors associated with treatment retention in pregnant women with opioid use disorders prescribed methadone or electing non-pharmacological treatment
B Jancaitis, S Kelpin, S Masho, J May, NA Haug… - Women & …, 2020 - Taylor & Francis
Opioid use during pregnancy is rising, with an estimated 14–22% of women obtaining an
opioid prescription during pregnancy. Methadone maintenance therapy (MMT) has been the …
opioid prescription during pregnancy. Methadone maintenance therapy (MMT) has been the …
Auswertung der Betreuung und der Behandlung von opioidabhängigen Schwangeren: eine retrospektive Datenanalyse aus 15 Jahren Patientinnenversorgung
C Kaps - 2020 - refubium.fu-berlin.de
Einleitung: Opioidabhängigkeit in der Schwangerschaft ist bei international steigenden
Zahlen zunehmend eine Herausforderung für das Gesundheitswesen. Die Substitution mit …
Zahlen zunehmend eine Herausforderung für das Gesundheitswesen. Die Substitution mit …